ID: ALA5196909

Max Phase: Preclinical

Molecular Formula: C31H40N6O10

Molecular Weight: 656.69

Associated Items:

Representations

Canonical SMILES:  C[C@H](NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)O[C@H](OCc2ccccc2)[C@@H]1N=[N+]=[N-])C(=O)N[C@H](CCC(=O)OCc1ccccc1)C(N)=O

Standard InChI:  InChI=1S/C31H40N6O10/c1-18(29(42)35-22(28(32)41)13-14-24(39)44-16-20-9-5-3-6-10-20)34-30(43)19(2)46-27-25(36-37-33)31(47-23(15-38)26(27)40)45-17-21-11-7-4-8-12-21/h3-12,18-19,22-23,25-27,31,38,40H,13-17H2,1-2H3,(H2,32,41)(H,34,43)(H,35,42)/t18-,19+,22+,23+,25+,26+,27+,31-/m0/s1

Standard InChI Key:  ZKISXNRYVNDSQA-FBDJJGPPSA-N

Associated Targets(Human)

Nucleotide-binding oligomerization domain-containing protein 2 1613 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Peritoneal macrophage 1554 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 656.69Molecular Weight (Monoisotopic): 656.2806AlogP: 0.73#Rotatable Bonds: 17
Polar Surface Area: 244.50Molecular Species: ACIDHBA: 11HBD: 5
#RO5 Violations: 2HBA (Lipinski): 16HBD (Lipinski): 6#RO5 Violations (Lipinski): 3
CX Acidic pKa: -10.30CX Basic pKa: CX LogP: 0.58CX LogD: 0.47
Aromatic Rings: 2Heavy Atoms: 47QED Weighted: 0.07Np Likeness Score: 0.66

References

1. Reddy PRS, Sambyal S, Mhamane TB, Sravanthi V, Shafi S, Khan IA, Sampath Kumar HM..  (2022)  Synthesis and biological evaluation of novel 2-azido muramyl dipeptide as NOD2 agonistic adjuvants.,  66  [PMID:35569249] [10.1016/j.bmc.2022.116781]

Source